Erin Jospe, MD, and Chris Gervais of Kyruus discuss how the company partners with health care organizations to help improve their COVID-19 vaccine rollout.
The United States is now 5 months into its national vaccine rollout. Although hundreds of millions of doses have been successfully administered, the process has hit several snags along the way, including, but not limited to, disparities in administration and a failure to collect racial data on nearly half of those vaccinated at the national level.
But to achieve this feat, health systems have had to adjust to shifting vaccine eligibility requirements, ensure outreach efforts are successful, and combat misinformation within their communities, all the while scheduling appointments and making sure shots get in arms.
In an effort to meet some of the logistical challenges of the rollout, Kyruus works alongside health care organizations and provides search, scheduling, and data management solutions to help connect patients with the right care.
On this episode of Managed Care Cast, we speak with Chris Gervais, the chief technology and security officer at Kyruus, and Erin Jospe, MD, chief medical officer at Kyruus.
Listen above or through one of these podcast services:
Care Quality Metrics in Medicare During COVID-19 Pandemic
August 12th 2025Medicare Advantage outperformed traditional Medicare on clinical quality measures before and during the COVID-19 pandemic; mid-pandemic, however, traditional Medicare narrowed the gap on some in-person screenings.
Read More
What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD
August 5th 2025Explore innovative strategies to enhance heart failure treatment through guideline-directed medical therapy, remote monitoring, and artificial intelligence–driven solutions for better patient outcomes.
Listen
Semaglutide Linked to Cardiovascular Gains, but Also Higher Health Spending
August 8th 2025A real-world study found that semaglutide prescriptions were associated with improvements in weight, blood pressure, and cholesterol, but also a $80 monthly rise in health care spending outside of drug costs.
Read More